• We have a team of IP specialist who can guide us the process development and IP related study to file the patents/trademarks/copyrights in continuation to the novel process developments, products or designs made at Lorven Biologics.

The innovative technologies and products developed by us enjoy patent protection as inventor’s privilege, while contributing to advancement of science and technology for societal benefit. We hold following patents currently in our portfolio, with many more in the submission pipeline.

1. Process for preparation of Liraglutide using recombinant Saccharomyces cerevisiae

 (WO2019082138A1)

2. Nucleic acid encoding CRM197 and process for improved expression thereof

 (WO2019043593A1)

3. Novel technology for snake bite detection

(IN201841028197A)

4. Novel molecular tools for development of low glycemic foods (management of diabetes)

(WO2018092155A1)

Partnering with us:

We support flexible business models, ranging from collaboration for co-development, contract development and manufacturing, partnership for commercialization of products, to intellectual property licensing. We will be glad to explore with you the partnership path that best suits mutual interests and needs. Don’t hesitate to contact us using following details:

Name of contact person:

Email:

Tel:

We are curiously waiting to discuss with you.